Selective and Orally Bioavailable Phenylglycine Tissue Factor/Factor Viia Inhibitors
Groebke-Zbinden, K., Obst-Sander, U., Hilpert, K., Kuehne, H., Banner, D.W., Boehm, H.-J., Stahl, M., Ackermann, J., Alig, L., Weber, L., Wessel, H.P., Riederer, M.A., Tschopp, T.B., Lave, T.(2005) Bioorg Med Chem Lett 15: 5344
- PubMed: 16213138 
- DOI: https://doi.org/10.1016/j.bmcl.2005.04.079
- Primary Citation of Related Structures:  
1W7X, 1W8B - PubMed Abstract: 
We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor VIIa inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway.
Organizational Affiliation: 
F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland. katrin.groebke_zbinden@roche.com